BNP Paribas Leasing Solutions and Syneron Medical Announce New European Financing Framework Agreement
24 Febrero 2011 - 8:00AM
Marketwired
BNP Paribas Leasing Solutions and Syneron Medical Ltd. (NASDAQ:
ELOS), the leading global aesthetic device company, are pleased to
announce that the companies have signed a European framework
agreement for vendor financing in the medical sector.
Following the successful implementation of vendor finance
programs throughout the United States and Canada, Syneron has
chosen to develop a similar program throughout Europe and has
selected BNP Paribas Leasing Solutions as its key partner.
The initial European framework agreement signed by the group
covers the following countries: France, Italy, Portugal, Spain, UK
and Germany, with plans to expand into other countries at a future
date.
The agreement will provide Syneron's customers, which include
dermatologists, plastic surgeons, family practitioners and other
physicians, and medical spa professionals, with better overall
choices for equipment acquisition and financial products. Through
BNP Paribas Leasing Solutions, financial products such as finance
leases or renting contracts, which may include variable payments
schedules and irregular payments streams, are just a few of the
financial products that will be available to Syneron's
customers.
The partnership between BNP Paribas Leasing Solutions and
Syneron will allow both companies to benefit from the expected
market growth for medical aesthetic devices. This market expansion
is expected to be driven by an increasing number of consumers,
growing demand for non-invasive procedures, continued technological
innovation and focus on direct to consumer marketing.
About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global
aesthetic device company with a comprehensive product portfolio and
a global distribution footprint. The Company's technology enables
physicians to provide advanced solutions for a broad range of
medical-aesthetic applications including body contouring, hair
removal, wrinkle reduction, rejuvenation of the skin's appearance
through the treatment of superficial benign vascular and pigmented
lesions, and the treatment of acne, leg veins and cellulite. The
Company sells its products under two distinct brands, Syneron and
Candela. Founded in 2000, the corporate, R&D, and manufacturing
headquarters for Syneron Medical Ltd. are located in Israel.
Syneron also has R&D and manufacturing operations in the US.
The company markets and services and supports its products in 86
countries. It has offices in North America, France, Germany, Italy,
Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and
distributors worldwide. Additional information can be found at
www.syneron.com.
BNP Paribas Leasing Solutions, far more than
finance...
BNP Paribas Leasing Solutions is the brand of the business line
within BNP Paribas that is specialised in leasing and rental
solutions for professional equipment and in real estate assets,
offered either directly to businesses and professionals or through
its partners -- manufacturers, publishers and their distribution
channels (dealers and resellers).
With more than EUR 32.2 billion of outstandings under management
and 3,600 employees located worldwide, BNP Paribas Leasing
Solutions is the European leader in equipment leasing and is today
the only financial institution with such a wide-ranging offer,
extending from simple leasing arrangements to long term rental
solutions and IT asset management contracts.
Thanks to its both global and local dimension, BNP Paribas
Leasing Solutions is able to offer services and solutions that
create value in 23 countries worldwide: directly in Austria,
Belgium, China, France, Germany, Hungary, India (Financial Company
with SREI), Italy, Luxemburg, Netherlands, Poland, Portugal,
Romania, Spain, Switzerland, Turkey, United Kingdom, Ukraine ;
through BNP Paribas Group entities in Algeria (El Djazaïr), Egypt
(BNP Paribas Egypt), Morocco (BMCI Leasing), Tunisia (UBCI
Leasing), and USA (Trinity Vendor Finance).
Press contacts: Karine Rifai 01 41 97 21 01 Email Contact
Severin Guiton 01 41 97 20 02 Email Contact Syneron
Contacts: Asaf Alperovitz Chief Financial Officer + 972 73 244
2283 Email: Email Contact Nick Laudico/Zack Kubow The Ruth Group
646-536-7030/7020 Email: Email Contact / Email Contact
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024